Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study

Expenditures for HIV-infection are driven mainly by drug costs. We identified several clinical variables influencing the costs of HIV-treatment. This information could assist policymakers when allocating limited health care resources to HIV care. </AbstractSection> Copyright Springer-Verlag 2013

MoreLess

Year of publication:	2013
Authors:	Mostardt, Sarah ; Hanhoff, Nikola ; Wasem, Jürgen ; Goetzenich, Armin ; Schewe, Knud ; Wolf, Eva ; Mayr, Christoph ; Jaeger, Hans ; Pfaff, Holger ; Dupke, Stephan ; Neumann, Anja
Published in:	The European Journal of Health Economics. - Springer. - Vol. 14.2013, 5, p. 799-808
Publisher:	Springer
Subject:	Cost of illness \| HIV \| AIDS \| Germany \| HAART \| Ambulatory care

More details

Extent:	text/html
Type of publication:	Article
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10010993926